Baldwin Investment Management LLC Acquires 158 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Baldwin Investment Management LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,743 shares of the medical equipment provider’s stock after acquiring an additional 158 shares during the quarter. Intuitive Surgical comprises about 0.6% of Baldwin Investment Management LLC’s portfolio, making the stock its 22nd largest holding. Baldwin Investment Management LLC’s holdings in Intuitive Surgical were worth $4,786,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of ISRG. Creekmur Asset Management LLC grew its holdings in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. LRI Investments LLC bought a new stake in Intuitive Surgical in the first quarter worth $30,000. Finally, LGT Financial Advisors LLC boosted its holdings in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 54 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 1.0 %

Intuitive Surgical stock opened at $542.10 on Wednesday. The company has a fifty day simple moving average of $506.81 and a 200-day simple moving average of $466.29. The firm has a market capitalization of $193.09 billion, a price-to-earnings ratio of 87.15, a PEG ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Leerink Partners raised their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $526.06.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,647 shares of company stock worth $26,170,907 over the last quarter. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.